Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
auditory evoked brainstem potentials
cerebrospinal fluid, oligoclonal IgG in
disability rating scale, neurological
disability, neurological
gait disorder
L-dopa
MRI
MRI, abnormal
multiple sclerosis
multiple sclerosis, diagnosis of
multiple sclerosis, late-onset
multiple sclerosis, prognosis
myelopathy
myelopathy, chronic progressive
neuromyelitis optica (Devic's disease)
old age, neurology of
Parkinson disease
Parkinson disease, late onset
Parkinson disease, treatment of
Parkinson disease, young onset
treatment of neurologic disorder
visual evoked response
Showing articles 1550 to 1600 of 5308 << Previous Next >>

Pattern and Concentration of IgG in Cerebrospinal Fluid in Neurosarcoidosis
Neurol 39:1637-1639, Scott,T.F.,et al, 1989

Bilateral Ballism in Multiple Sclerosis
Neurol 39:1641-1642, Masucci,E.F.,et al, 1989

The Influence of Pregnancy on Disability From Multiple Sclerosis:A Population in Middlesex County, Ontario
Neurol 39:1438-1440, Weinshenker,B.G.,et al, 1989

Caring at Night for People with Multiple Sclerosis
BMJ 299:1433, Spackman,A.J.,et al, 1989

Chronic Progressive Myelopathy Associated with HTLV-I:Oligoclonal IgG and Anti-HTLV-I IgG Antibodies in CSF & Serum
Neurol 39:1566-1572, Link,H.,et al, 1989

Investigation of Failed Low Back Surgery
Editorial, Lancet 1:939-9401989., , 1989

Neck Sprains after Car Accidents, A Common Cause of Long Term Disability
BMJ 298:973-974, Porter,K.M., 1989

Non Ischaemic Causes of Lacunar Syndromes:Prevalence and Clinical Findings
JNNP 52:1188-1190, Anzalone,N.&Landi,G., 1989

Brain Damage by Neonatal Hypoglycaemia
Editorial, Lancet 1:882-8831989., , 1989

Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989

Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989

Magnetism, A New Method for Stimulation of Nerve and Brain
JAMA 262:538-541, Hallett,M.&Cohen,L.G., 1989

Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989

Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989

Multiple Sclerosis Simulating Brain Tumor on Computed Tomography
J Comput Assist Tomogr 13:674-678, Otsuka,S.I.,et al, 1989

Cerebrospinal Fluid Immunoglogulins & MS, Correspondence MRI & Visually Evoked Potential Changes
Arch Neurol 46:367-371, Miller,F.A.J.,et al, 1989

The Lesion of Multiple Sclerosis:Imaging of Acute and Chronic Stages
Neurol 39:959-963, Koopmans,R.A.,et al, 1989

Chronic Progressive Multiple Sclerosis:Serial Magnetic Resonance Brain Imaging Over Six Months
Ann Neurol 26:248-256, Koopmans,R.A.,et al, 1989

Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989

Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989

A Placebo-Controlled, Randomized, Clinical Trial of Azathioprine with & without Methylpred in MS
Neurol 39:1018-1026, Ellison,G.W.,et al, 1989

Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989

Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989

Central Nervous System Manifestations of Lyme Disease
Arch Neurol 46:790-795, Pachner,A.R.,et al, 1989

Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989

Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989

Inflammatory Myelinoclastic Diffuse Sclerosis (Schilder's Disease) :Neuroradiological Findings
AJNR 10:176-180, Mehler,M.F.&Rabinowich,L., 1989

Clinical Presentations of Vascular Malformations of the Brain Stem:Comparison of Angiographically Positive and Negative Types
JNNP 52:167-175, Abe,M.,et al, 1989

The Disability Status Scale for Multiple Sclerosis:Apologia Pro DSS Sau
Neurol 39:291-302, Kurtzke,J.F., 1989

Cognitive Loss in Multiple Sclerosis
Arch Neurol 46:162-167, Franklin,G.M.,et al, 1989

Correlation of Magnetic Resonance Imaging with Neuropsychological Testing in Multiple Sclerosis
Neurol 39:161-166, Rao,S.M.,et al, 1989

Consensus and Controversy in Neurologic Practice, The Case of Steroid Treatment in Multiple Sclerosis
Arch Neurol 46:322, Menken,M., 1989

Quantitative Magnetic Resonance Imaging in Multiple Sclerosis:The Effect of High Dose Intravenous Methylprednisolone
JNNP 52:14-17, Kesselring,J.,et al, 1989

Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989

Sneddon Syndrome:CT, Arteriography, and MR Imaging
J Comput Assist Tomogr 13:119-122, Blom,R.J., 1989

Clinicopath Conf
Primary (Granulomatous) Angiitis of Central Nervous System, Case Record 8-1989, NEJM 320:514-5249., , 1989

The Prevalence of Primary Sjogren's Syndrome in a Multiple Sclerosis Population
Ann Neurol 25:95-98, Noseworthy,J.H.,et al, 1989

Multiple Sclerosis-Like Illness Occurring with Human Immunodeficiency Virus Infection
Neurol 39:324-329, Berger,J.R.,et al, 1989

Chronic Myelopathies Associated with HTLV-I, A Clinical, Serologic, and Immunovirologic Study of 10 Patients in France
Arch Neurol 46:255-260, Gout,O.,et al, 1989

Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989

Significance of the Argyll Robertson Pupil in Clinical Medicine
Am J Med 86:199-202, Dacso,C.C.&Bortz,D.L., 1989

Hemorrhagic Shock and Encephalopathy:Clinical, Pathologic, and Biochemical Features
J Pediatr 114:194-203, Levin,M.,et al, 1989

Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989

Serial Magnetic Resonance Scanning in Multiple Sclerosis:A Second Prospective Study in Relapsing Patients
Ann Neurol 25:43-49, Willoughby,E.W.,et al, 1989

Benign Versus Chronic Progressive Multiple Sclerosis:Magnetic Resonance Imaging Features
Ann Neurol 25:74-81, Koopmans,R.A.,et al, 1989

Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease
NEJM 321:762-763, Sadovnick,A.D.,et al, 1989

Short-Term Outcomes of Skull Fracture:A Population-Based Study of Survival and Neurologic Complications
Neurol 39:96-102, Wiederholt,W.C.,et al, 1989

Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989

Relative Diagnostic Value of Cerebrospinal Fluid Kappa Chains in MS:Comparison with Other Immunoglobulin Tests
Neurol 39:964-968, Rudnick,R.A.,et al, 1989

Patterns of Neurologic Involvement in Multiple Sclerosis
Neurol 39:1235-1238, Kurtzke,J.F., 1989



Showing articles 1550 to 1600 of 5308 << Previous Next >>